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Introduction: Janus-dendrimers are synthetic amphiphiles formed by linking two chemically distinct 
hydrophilic and hydrophobic dendrons by their core, which can self-assemble as vesicles (dendrimersomes) 
or fibres in aqueous solutions, as well as in biological media. This research shows that the dendrimersomes 
can differentially encapsulate drug compounds, are stable for long periods of time, and can be annealed from 
22 °C to 70 °C with minimal change (2-5 nm) in their hydrodynamic radius [1]. Also, by modulating the 
hydrophilic branch generation we found that Janus-dendrimers were also able to self-assemble into a variety 
of other architectures such as fibres, giving rise to supramolecular hydrogels capable of encapsulating and 
releasing small molecules, peptides, and proteins [2], or even function as colloidal suspensions’ stabilizers 
[3]. Thus, the small library of Janus-dendrimers reported herein expand the scope of dendrimer-based 
supramolecular drug delivery systems and suggest that these materials can be further used in biomedical 
sol–gel applications. 
 
Methods: Amphiphilic Janus dendrimers were obtained via a copper-catalyzed click-chemistry reaction 
combining propargyl-modified bis-MPA dendrons and Percec-type hydrophobic azide dendrons into a single 
molecule. The resulting molecules were characterized using NMR, MALDI-TOF and DSC. The structures were 
then diluted into ethanolic solutions and directly injected into water or other biologically relevant media to 
obtain either vesicles or hydrogels. Both molecular arrangements were then imaged by electron microscopy. 
Characterization of the vesicles included measuring size and stability by DLS as a function of time and 
temperature, whereas the hydrogels were characterized by conducting rheological and SAXS measurements. 
The compound encapsulation in the vesicles was examined by confocal microscopy and the release was 
monitored by UV spectroscopy. The small molecule, peptide, and protein release from the hydrogels was 
monitored by HPLC (small molecule and peptide) or spectrometry (protein). 
 
Results: The vesicles obtained through ethanol injection were remarkably uniform (PDI <0.02) and ranged 
from 77 to 240 nm depending 
on the arrangement of 
hydrophobic dendron, the 
generation of the hydrophilic 
dendron and the solvent from 
which they were injected from 
(Fig. 1A). When prepared by 
film hydration, the 
dendrimersomes were ca. 10 
µm in diameter (Fig. 1B). The 
hydrogel-constituting 
Fig. 1 (A) Cryo-TEM of ethanol-injected dendrimersomes, (B) Confocal microscope 
imaging of film-hydrated dendrimersomes, and (C) Cryo-TEM of ethanol-injected 
supramolecular fibres. Scale bars are 100 nm in (A) and (C), and 10 µm in (B).  
supramolecular fibres were between 4.8 and 5.6 nm assessed by electron microscopy (Fig. 1C) and SAXS. The 
dendrimersomes could encapsulate and release the drug propranolol upon stimulus (Fig. 2A), whereas the 
release of the drugs from the hydrogels followed a first-order kinetics (Fig. 2B).  
Conclusion: This report highlights, for 
the first time, the chemical versatility 
and robustness offered by Janus-
dendrimers supramolecular 
architectures for drug delivery 
applications and the translation 
potential of these structures into the 
clinical setting. 
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Learning Objectives  
Identify the impact of the hydrophilic/hydrophobic dendron balance in Janus-dendrimers self-assembly 
Differentiate between the different approaches for dendrimersomes self-assembly 
Explain the advantages of dendrimersomes as colloidal drug delivery systems 
Evaluate the factors affecting the differential drug release profiles from the Janus-dendrimer hydrogels 
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Fig. 2 (A), propranolol loaded into dendrimersomes (red and black, respectively) 
measured by relative fluorescence. Arrows denote the time when 50 μL 3% Triton 
X-100 solution was added in order to disrupt the samples and the control. Error bars 
represent ± SD (n = 3). (B) Release of nadolol (small-molecule drug), gonadorelin 
(decapeptide), and HRP (protein) from 0.2 wt% Janus-dendrimer hydrogel. 
